Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07287826 · ClinicalTrials.gov registry record · Phase 4
Using a Steroid Mouthwash to Prevent Mouth Sores During Chemotherapy
A Phase 4 study, sponsored by Woman's.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
NCT07287826 is a Phase 4 study that is actively recruiting participants, run by Woman's. The registered enrollment target is 45 participants.
The verdict
NCT07287826, a Phase 4 study, is actively recruiting participants, sponsored by Woman's.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if a steroid mouthwash (dexamethasone) can prevent mouth sores caused by chemotherapy in adults with cancer. The main questions it aims to answer are: Does using dexamethasone mouthwash before and during chemotherapy lower the chance of getting moderate to severe mouth sores? Can this approach reduce pain and improve comfort during chemotherapy? Researchers will compare patients using the mouthwash to a historical group of patients who received similar chemotherapy but did not use the mouthwash, to see if the mouthwash helps prevent mouth sores. Participants will: Use a steroid mouthwash (4 times daily) for up to 8 weeks during chemotherapy Complete a short weekly survey about mouth discomfort during infusion visits
Interventions
- DRUG Dexamethasone Mouthwash
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-04-02 |
| Est. Completion | 2028-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07287826
The ClinicalTrials.gov registry entry for NCT07287826 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Woman's, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexamethasone Mouthwash is the first listed.
NCT07287826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07287826 about?
NCT07287826 is a clinical study titled "Using a Steroid Mouthwash to Prevent Mouth Sores During Chemotherapy". The goal of this clinical trial is to learn if a steroid mouthwash (dexamethasone) can prevent mouth sores caused by chemotherapy in adults with cancer. The main questions it aims to answer are: Does using dexamethasone mouthwash before and during chemotherapy lower the chance of getting moderate t...
What is the current status of trial NCT07287826?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2026-04-02. Estimated completion is 2028-01.
What interventions are being tested in trial NCT07287826?
The interventions under investigation include: Dexamethasone Mouthwash (DRUG).
Who is sponsoring clinical trial NCT07287826?
This trial is sponsored by Woman's, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.